Lifeboat Foundation

MIT engineers have developed a continuous manufacturing process that produces long strips of high-quality graphene.

The team’s results are the first demonstration of an industrial, scalable method for manufacturing high-quality graphene that is tailored for use in membranes that filter a variety of molecules, including salts, larger ions, proteins, or nanoparticles. Such membranes should be useful for desalination, biological separation, and other applications.

Continue reading “Scalable manufacturing process spools out strips of graphene for use in ultrathin membranes” »

Researchers in the US and UK examined an existing enzyme which had occurred naturally in landfill sites and was able to slowly digest man-made plastics.

But in the course of testing the enzyme’s origins, the researchers made biological changes to it that turbo-charged its ability to digest plastics, according to Britain’s University of Portsmouth.

According to The Guardian, the enzyme starts breaking down plastic in a matter of days, a process which would take centuries under normal conditions.

Continue reading “Scientists accidentally discovered a mutant enzyme that could help the world eliminate plastic waste” »

http://www.corebrainjournal.com/2018/04/211-regenerative-bio…cs-pastor/

We created the first working AI using the theory of practopoiesis. We are still far away from biological intelligence, but still we have something much better than classical machine learning. You can play with a live demo here:

Kazan, Russia, April 23–25.

23–25 April 2018 in Kazan (Russia) will be a biogerontological conference with the following main topics:

Continue reading “International conference «Interventions to extend healthspan and lifespan»” »

In 2017, synthetic biology companies raised a record amount of funding – just over $1.8 billion for fifty two companies – driven mostly by several multi-hundred million dollar deals. This was a 50% increase over the previous year, a pace of growth that indicated an intense interest in the field from outside investors. It seems that this interest has only intensified since then, as 27 companies raised $650 million in funding during the first quarter of 2018, which is double the activity of the first quarter of 2017. At this rate, the field is on track to raise over $2.4 billion with over 100 companies being funded, which would be a record for both statistics.

The companies raising money in 2018 are pursuing a broadly diverse set of applications from all sections of the synthetic biology technology stack. Many companies are developing products that will eventually end up in the hands (or bodies) of everyday consumers, but others are making the tools and reagents that will empower the whole field to become more productive. It is important that all of these types of companies exist in order to build a healthy industry ecosystem.

Continue reading “Synthetic biology companies raised over $650 million in Q1, setting the pace for another record-breaking year” »

Elon Musk’s neurotechnology startup Neuralink filed for permits to build an in-house machine shop and a biological testing laboratory for its facility in San Francisco last year.

The documentation on the company’s 2017 permits was retrieved by Gizmodo, which was able to access Neuralink’s public records. An excerpt of a letter submitted by Neuralink executive Jared Birchall on February 2017 to the city’s planning department gives some clues about the company’s plans for the facility’s proposed machine shop and animal testing lab.